🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare the radiographic progression-free s...
Status
Active Not Recruiting
Location
Multiple Locations
Start Date
2014-11-26
Trial ID
NCT02257736
Treatments Being Tested
Hormone therapy, or androgen deprivation therapy (ADT) is a standard way to...
Status
Recruiting
Location
Clearview Cancer Institute
Start Date
2025-08-19
Trial ID
NCT07005154
Treatments Being Tested
The purpose of this study is to evaluate safety and efficacy of abiraterone...
Status
Completed
Location
Multiple Locations
Start Date
2009-11
Trial ID
NCT00924469
Treatments Being Tested
Metastatic castration resistant prostate cancer causes approximately 258400...
Status
Unknown
Location
Multiple Locations
Start Date
2018-05-01
Trial ID
NCT03449719
Treatments Being Tested
This phase II trial studies the effect of androgen ablation therapy with or...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2021-08-05
Trial ID
NCT04947254
Treatments Being Tested
The purpose of this study is to evaluate the pharmacokinetics (how the drug...
Status
Completed
Location
Multiple Locations
Start Date
2007-07
Trial ID
NCT00600535
This study is to find out whether adding the study drug atezolizumab and st...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Start Date
2020-03-03
Trial ID
NCT04262154
To assess the safety of treating men with oligometastatic prostate cancer w...
Status
Completed
Location
Johns Hopkins Sibley Memorial Hospital
Start Date
2017-02-22
Trial ID
NCT03043807
Treatments Being Tested
The purpose of this study is to investigate the safety and efficacy of a ne...
Status
Completed
Location
Research Site
Start Date
2021-05-05
Trial ID
NCT04887506
Treatments Being Tested
Study Design : A randomized, open-label, four-sequence, four-period, crosso...
Status
Completed
Location
Seoul National University Hospital
Start Date
2023-08-10
Trial ID
NCT06014853